25 XP   0   0   10

Windlas Biotech Ltd
Buy, Hold or Sell?

Let's analyse Windlas Biotech Ltd together

PenkeI guess you are interested in Windlas Biotech Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Windlas Biotech Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Windlas Biotech Ltd

I send you an email if I find something interesting about Windlas Biotech Ltd.

Quick analysis of Windlas Biotech Ltd (30 sec.)










What can you expect buying and holding a share of Windlas Biotech Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.17
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
INR192.23
Expected worth in 1 year
INR236.60
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
INR58.95
Return On Investment
13.9%

For what price can you sell your share?

Current Price per Share
INR424.15
Expected price per share
INR384.25 - INR
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Windlas Biotech Ltd (5 min.)




Live pricePrice per Share (EOD)

INR424.15

Intrinsic Value Per Share

INR-51.43 - INR-61.76

Total Value Per Share

INR140.80 - INR130.47

2. Growth of Windlas Biotech Ltd (5 min.)




Is Windlas Biotech Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$48.2m$47.3m$899.2k1.9%

How much money is Windlas Biotech Ltd making?

Current yearPrevious yearGrowGrow %
Making money$5.1m$4.5m$544.4k10.6%
Net Profit Margin8.3%8.2%--

How much money comes from the company's main activities?

3. Financial Health of Windlas Biotech Ltd (5 min.)




3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Windlas Biotech Ltd? (5 min.)

Welcome investor! Windlas Biotech Ltd's management wants to use your money to grow the business. In return you get a share of Windlas Biotech Ltd.

What can you expect buying and holding a share of Windlas Biotech Ltd?

First you should know what it really means to hold a share of Windlas Biotech Ltd. And how you can make/lose money.

Speculation

The Price per Share of Windlas Biotech Ltd is INR424.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Windlas Biotech Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Windlas Biotech Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR192.23. Based on the TTM, the Book Value Change Per Share is INR11.09 per quarter. Based on the YOY, the Book Value Change Per Share is INR89.77 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR3.65 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Windlas Biotech Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.240.1%0.240.1%0.210.0%0.160.0%0.160.0%
Usd Book Value Change Per Share0.130.0%0.130.0%1.080.3%0.580.1%0.580.1%
Usd Dividend Per Share0.040.0%0.040.0%0.000.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.180.0%0.180.0%1.080.3%0.590.1%0.590.1%
Usd Price Per Share2.70-2.70-2.52-1.31-1.31-
Price to Earnings Ratio11.06-11.06-12.02-5.77-5.77-
Price-to-Total Gains Ratio15.28-15.28-2.34-8.81-8.81-
Price to Book Ratio1.17-1.17-1.16-0.58-0.58-
Price-to-Total Gains Ratio15.28-15.28-2.34-8.81-8.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.0898
Number of shares196
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.01
Usd Book Value Change Per Share0.130.58
Usd Total Gains Per Share0.180.59
Gains per Quarter (196 shares)34.66115.17
Gains per Year (196 shares)138.65460.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1341041299452451
26920926817904912
31033134072613561373
41374175463418081834
51715226854322612295
62066268245127132756
72407309636031653217
827483511026936173678
930993912417740694139
10343104413808645214600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.01.00.075.0%3.01.00.075.0%3.01.00.075.0%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%1.00.03.025.0%1.00.03.025.0%1.00.03.025.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.01.00.075.0%3.01.00.075.0%3.01.00.075.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Windlas Biotech Ltd

About Windlas Biotech Ltd

  • 1049

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO services, including product discovery, product development, licensing, and commercial manufacturing of generic products. It manufactures nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, and chewable or dispersible. The company was incorporated in 2001 and is based in Gurugram, India.

Fundamental data was last updated by Penke on 2023-11-12 10:42:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Windlas Biotech Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Windlas Biotech Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Windlas Biotech Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 8.3% means that ₹0.08 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Windlas Biotech Ltd:

  • The MRQ is 8.3%. The company is making a profit. +1
  • The TTM is 8.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.3%TTM8.3%0.0%
TTM8.3%YOY8.2%+0.1%
TTM8.3%5Y6.3%+2.0%
5Y6.3%10Y6.3%0.0%
1.1.2. Return on Assets

Shows how efficient Windlas Biotech Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Windlas Biotech Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 8.1% Return on Assets means that Windlas Biotech Ltd generated ₹0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Windlas Biotech Ltd:

  • The MRQ is 8.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.1%TTM8.1%0.0%
TTM8.1%YOY7.8%+0.3%
TTM8.1%5Y6.5%+1.6%
5Y6.5%10Y6.5%0.0%
1.1.3. Return on Equity

Shows how efficient Windlas Biotech Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Windlas Biotech Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.6% Return on Equity means Windlas Biotech Ltd generated ₹0.11 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Windlas Biotech Ltd:

  • The MRQ is 10.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.6%TTM10.6%0.0%
TTM10.6%YOY9.6%+0.9%
TTM10.6%5Y9.0%+1.6%
5Y9.0%10Y9.0%0.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Windlas Biotech Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Windlas Biotech Ltd is operating .

  • Measures how much profit Windlas Biotech Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Windlas Biotech Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Windlas Biotech Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Windlas Biotech Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.54 means that the operating costs are ₹1.54 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 1.541. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.541. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.541TTM1.5410.000
TTM1.541YOY1.566-0.025
TTM1.5415Y1.548-0.007
5Y1.54810Y1.5480.000
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Windlas Biotech Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Windlas Biotech Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.92 means the company has ₹2.92 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 2.916. The company is able to pay all its short-term debts. +1
  • The TTM is 2.916. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.916TTM2.9160.000
TTM2.916YOY4.061-1.145
TTM2.9165Y2.599+0.317
5Y2.59910Y2.5990.000
1.3.2. Quick Ratio

Measures if Windlas Biotech Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Windlas Biotech Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.03 means the company can pay off ₹2.03 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 2.034. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.034. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.034TTM2.0340.000
TTM2.034YOY3.045-1.011
TTM2.0345Y1.758+0.276
5Y1.75810Y1.7580.000
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Windlas Biotech Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Windlas Biotech Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Windlas Biotech Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.24 means that Windlas Biotech Ltd assets are financed with 24.0% credit (debt) and the remaining percentage (100% - 24.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 0.240. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.240. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.240TTM0.2400.000
TTM0.240YOY0.196+0.044
TTM0.2405Y0.286-0.046
5Y0.28610Y0.2860.000
1.4.2. Debt to Equity Ratio

Measures if Windlas Biotech Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Windlas Biotech Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 31.5% means that company has ₹0.31 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 0.315. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.315. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.315TTM0.3150.000
TTM0.315YOY0.244+0.071
TTM0.3155Y0.415-0.100
5Y0.41510Y0.4150.000
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Windlas Biotech Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Windlas Biotech Ltd generates.

  • Above 15 is considered overpriced but always compare Windlas Biotech Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 11.06 means the investor is paying ₹11.06 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Windlas Biotech Ltd:

  • The EOD is 20.823. Based on the earnings, the company is fair priced.
  • The MRQ is 11.056. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.056. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD20.823MRQ11.056+9.767
MRQ11.056TTM11.0560.000
TTM11.056YOY12.022-0.966
TTM11.0565Y5.769+5.286
5Y5.76910Y5.7690.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Windlas Biotech Ltd:

  • The EOD is -89.431. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -47.483. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -47.483. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-89.431MRQ-47.483-41.948
MRQ-47.483TTM-47.4830.000
TTM-47.483YOY-80.701+33.219
TTM-47.4835Y-32.046-15.437
5Y-32.04610Y-32.0460.000
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Windlas Biotech Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.17 means the investor is paying ₹1.17 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Windlas Biotech Ltd:

  • The EOD is 2.206. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.172. Based on the equity, the company is underpriced. +1
  • The TTM is 1.172. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.206MRQ1.172+1.035
MRQ1.172TTM1.1720.000
TTM1.172YOY1.160+0.012
TTM1.1725Y0.583+0.589
5Y0.58310Y0.5830.000
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Windlas Biotech Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--11.09211.0920%89.775-88%48.057-77%48.057-77%
Book Value Per Share--192.229192.2290%181.137+6%140.232+37%140.232+37%
Current Ratio--2.9162.9160%4.061-28%2.599+12%2.599+12%
Debt To Asset Ratio--0.2400.2400%0.196+22%0.286-16%0.286-16%
Debt To Equity Ratio--0.3150.3150%0.244+29%0.415-24%0.415-24%
Dividend Per Share--3.6453.6450%-+100%0.911+300%0.911+300%
Eps--20.36920.3690%17.477+17%13.137+55%13.137+55%
Free Cash Flow Per Share---4.743-4.7430%-2.603-45%-0.081-98%-0.081-98%
Free Cash Flow To Equity Per Share---4.743-4.7430%-2.603-45%-0.081-98%-0.081-98%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---61.758--------
Intrinsic Value_10Y_min---51.432--------
Intrinsic Value_1Y_max---2.588--------
Intrinsic Value_1Y_min---2.515--------
Intrinsic Value_3Y_max---10.520--------
Intrinsic Value_3Y_min---9.887--------
Intrinsic Value_5Y_max---21.761--------
Intrinsic Value_5Y_min---19.756--------
Market Cap8821726190.000+47%4712676625.6004712676625.6000%4578998187.500+3%2322918703.275+103%2322918703.275+103%
Net Profit Margin--0.0830.0830%0.082+1%0.063+32%0.063+32%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.5411.5410%1.566-2%1.5480%1.5480%
Pb Ratio2.206+47%1.1721.1720%1.160+1%0.583+101%0.583+101%
Pe Ratio20.823+47%11.05611.0560%12.022-8%5.769+92%5.769+92%
Price Per Share424.150+47%225.200225.2000%210.100+7%108.825+107%108.825+107%
Price To Free Cash Flow Ratio-89.431-88%-47.483-47.4830%-80.701+70%-32.046-33%-32.046-33%
Price To Total Gains Ratio28.781+47%15.28115.2810%2.340+553%8.811+73%8.811+73%
Quick Ratio--2.0342.0340%3.045-33%1.758+16%1.758+16%
Return On Assets--0.0810.0810%0.078+4%0.065+24%0.065+24%
Return On Equity--0.1060.1060%0.096+10%0.090+18%0.090+18%
Total Gains Per Share--14.73714.7370%89.775-84%48.969-70%48.969-70%
Usd Book Value--48272520.00048272520.0000%47373240.000+2%36174780.000+33%36174780.000+33%
Usd Book Value Change Per Share--0.1330.1330%1.077-88%0.577-77%0.577-77%
Usd Book Value Per Share--2.3072.3070%2.174+6%1.683+37%1.683+37%
Usd Dividend Per Share--0.0440.0440%-+100%0.011+300%0.011+300%
Usd Eps--0.2440.2440%0.210+17%0.158+55%0.158+55%
Usd Free Cash Flow---1191000.000-1191000.0000%-680880.000-43%-8880.000-99%-8880.000-99%
Usd Free Cash Flow Per Share---0.057-0.0570%-0.031-45%-0.001-98%-0.001-98%
Usd Free Cash Flow To Equity Per Share---0.057-0.0570%-0.031-45%-0.001-98%-0.001-98%
Usd Market Cap105860714.280+47%56552119.50756552119.5070%54947978.250+3%27875024.439+103%27875024.439+103%
Usd Price Per Share5.090+47%2.7022.7020%2.521+7%1.306+107%1.306+107%
Usd Profit--5115120.0005115120.0000%4570680.000+12%3382800.000+51%3382800.000+51%
Usd Revenue--61569960.00061569960.0000%55604760.000+11%51947940.000+19%51947940.000+19%
Usd Total Gains Per Share--0.1770.1770%1.077-84%0.588-70%0.588-70%
 EOD+5 -3MRQTTM+0 -0YOY+18 -165Y+22 -1210Y+22 -12

3.2. Fundamental Score

Let's check the fundamental score of Windlas Biotech Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.823
Price to Book Ratio (EOD)Between0-12.206
Net Profit Margin (MRQ)Greater than00.083
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.034
Current Ratio (MRQ)Greater than12.916
Debt to Asset Ratio (MRQ)Less than10.240
Debt to Equity Ratio (MRQ)Less than10.315
Return on Equity (MRQ)Greater than0.150.106
Return on Assets (MRQ)Greater than0.050.081
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Windlas Biotech Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose434.750
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets5,289,750
Total Liabilities1,267,040
Total Stockholder Equity4,022,710
 As reported
Total Liabilities 1,267,040
Total Stockholder Equity+ 4,022,710
Total Assets = 5,289,750

Assets

Total Assets5,289,750
Total Current Assets3,535,360
Long-term Assets3,535,360
Total Current Assets
Cash And Cash Equivalents 36,860
Short-term Investments 1,297,500
Net Receivables 1,168,600
Inventory 747,380
Other Current Assets 285,020
Total Current Assets  (as reported)3,535,360
Total Current Assets  (calculated)3,535,360
+/-0
Long-term Assets
Intangible Assets 14,840
Long-term Assets Other 415,920
Long-term Assets  (as reported)1,754,390
Long-term Assets  (calculated)430,760
+/- 1,323,630

Liabilities & Shareholders' Equity

Total Current Liabilities1,212,420
Long-term Liabilities54,620
Total Stockholder Equity4,022,710
Total Current Liabilities
Short Long Term Debt 3,350
Accounts payable 877,430
Other Current Liabilities 41,460
Total Current Liabilities  (as reported)1,212,420
Total Current Liabilities  (calculated)922,240
+/- 290,180
Long-term Liabilities
Long term Debt 1,090
Capital Lease Obligations Min Short Term Debt45,490
Long-term Liabilities  (as reported)54,620
Long-term Liabilities  (calculated)46,580
+/- 8,040
Total Stockholder Equity
Retained Earnings 1,763,460
Total Stockholder Equity (as reported)4,022,710
Total Stockholder Equity (calculated)1,763,460
+/- 2,259,250
Other
Capital Stock104,630
Common Stock Shares Outstanding 20,927
Net Invested Capital 4,027,150
Net Working Capital 2,322,940



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-31
> Total Assets 
3,384,880
2,961,230
4,910,110
5,289,750
5,289,7504,910,1102,961,2303,384,880
   > Total Current Assets 
1,680,290
1,943,110
3,816,510
3,535,360
3,535,3603,816,5101,943,1101,680,290
       Cash And Cash Equivalents 
180,780
159,300
5,700
36,860
36,8605,700159,300180,780
       Short-term Investments 
225,860
383,250
1,754,560
1,297,500
1,297,5001,754,560383,250225,860
       Net Receivables 
639,380
794,130
1,107,720
1,168,600
1,168,6001,107,720794,130639,380
       Inventory 
493,170
414,610
587,100
747,380
747,380587,100414,610493,170
   > Long-term Assets 
1,704,590
1,018,120
1,093,600
1,754,390
1,754,3901,093,6001,018,1201,704,590
       Intangible Assets 
5,520
4,820
8,810
14,840
14,8408,8104,8205,520
> Total Liabilities 
1,288,290
970,040
962,340
1,267,040
1,267,040962,340970,0401,288,290
   > Total Current Liabilities 
1,252,890
934,190
939,860
1,212,420
1,212,420939,860934,1901,252,890
       Short Long Term Debt 
262,180
304,840
56,770
3,350
3,35056,770304,840262,180
       Accounts payable 
831,360
399,330
632,320
877,430
877,430632,320399,330831,360
       Other Current Liabilities 
0
0
15,040
41,460
41,46015,04000
   > Long-term Liabilities 
35,400
35,850
22,480
54,620
54,62022,48035,85035,400
       Long term Debt 
12,130
8,320
4,440
1,090
1,0904,4408,32012,130
       Capital Lease Obligations Min Short Term Debt
15,030
10,330
5,160
45,490
45,4905,16010,33015,030
       Long-term Liabilities Other 
0
0
40
0
04000
> Total Stockholder Equity
2,096,590
1,991,190
3,947,770
4,022,710
4,022,7103,947,7701,991,1902,096,590
   Common Stock0000
   Retained Earnings 
1,141,320
1,035,950
1,415,010
1,763,460
1,763,4601,415,0101,035,9501,141,320
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 0000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue5,130,830
Cost of Revenue-3,254,470
Gross Profit1,876,3601,876,360
 
Operating Income (+$)
Gross Profit1,876,360
Operating Expense-4,652,210
Operating Income478,620-2,775,850
 
Operating Expense (+$)
Research Development89,480
Selling General Administrative186,120
Selling And Marketing Expenses0
Operating Expense4,652,210275,600
 
Net Interest Income (+$)
Interest Income34,900
Interest Expense-7,880
Other Finance Cost-34,900
Net Interest Income-7,880
 
Pretax Income (+$)
Operating Income478,620
Net Interest Income-7,880
Other Non-Operating Income Expenses0
Income Before Tax (EBT)570,390478,620
EBIT - interestExpense = -7,880
426,260
434,140
Interest Expense7,880
Earnings Before Interest and Taxes (EBIT)0578,270
Earnings Before Interest and Taxes (EBITDA)701,910
 
After tax Income (+$)
Income Before Tax570,390
Tax Provision-144,130
Net Income From Continuing Ops426,260426,260
Net Income426,260
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net07,880
 

Technical Analysis of Windlas Biotech Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Windlas Biotech Ltd. The general trend of Windlas Biotech Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Windlas Biotech Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Windlas Biotech Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 416.52 > 392.35 > 384.25.

Tweet this
Windlas Biotech Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Windlas Biotech Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Windlas Biotech Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Moving Average Convergence/Divergence (MACD) ChartWindlas Biotech Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Windlas Biotech Ltd. The current adx is .

Windlas Biotech Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Relative Strength Index (RSI) ChartWindlas Biotech Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Stochastic Oscillator ChartWindlas Biotech Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Commodity Channel Index (CCI) ChartWindlas Biotech Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Chande Momentum Oscillator (CMO) ChartWindlas Biotech Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Williams %R ChartWindlas Biotech Ltd Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Average True Range (ATR) ChartWindlas Biotech Ltd Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily On-Balance Volume (OBV) ChartWindlas Biotech Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Money Flow Index (MFI) ChartWindlas Biotech Ltd Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Windlas Biotech Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-07-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-07-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-07-17MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-07-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-07-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-07-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-07-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-08-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-08-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-08-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-08-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-08-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-08-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-08-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-08-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-08-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-08-31STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-09-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-09-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-09-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-10-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-10-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-10-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-10-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-10-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-10-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Windlas Biotech Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Windlas Biotech Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose434.750
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Windlas Biotech Ltd with someone you think should read this too:
  • Are you bullish or bearish on Windlas Biotech Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Windlas Biotech Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Windlas Biotech Ltd

I send you an email if I find something interesting about Windlas Biotech Ltd.


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about Windlas Biotech Ltd.

Receive notifications about Windlas Biotech Ltd in your mailbox!